Table 2. Pendrin expression and localisation in relation to tumour size and TNM (tumour-node-metastasis) in analysed thyroid neoplasm.
| Patient | Sex/age | Histology | Tumour size (cm) | TNM | Pendrin immunostaining and localisation |
|---|---|---|---|---|---|
| BW | F/66 | PTC | 1.3 | T2aNo | +++; c |
| SJ | M/59 | PTC | 0.7 | T1aNo | ++; c |
| CH M | F/72 | PTC | 5 × 5 × 4 | T3a | +++; c |
| UB | F/39 | PTC | 2 × 1 × 1 | T2a | +++; c |
| LZ | F/72 | PTC | 2.2 | T2a | +++; c |
| AA | F/28 | PTC | 1.1 | T2a | ++; c |
| GW | M/54 | PTC | 1.2 | T2aNo | +++; c |
| KA | F/36 | PTC | 6; 2 | T3b | +++; c |
| KK | F/23 | PTC | 1.5; 2 | T2bNo | +++; c |
| MM | F/42 | PTC | 0.9 × 0.6 | T1a | +++; c |
| SM | F/54 | PTC | 1.4 | T2aNo | 0 |
| ZJ | F/70 | PTC | 1.8 × 1.1 × 1 | T2aNo | ++; c |
| KZ | F/63 | PTC | 1 × 1; 1 × 0.8 | T1bNo | +++; c |
| GJ | F/53 | PTC | 4; 1 | T2bNo | ++; c |
| SG | F/49 | PTC | 2.5 × 2 × 2 | T2aNo | 0 |
| TP | F/45 | PTC | 1.1; 1.5 | T2bNo | ++; c |
| GU | F/31 | PTC | 1.6 | T2aNo | +++; c |
| SB | F/49 | PTC | 1.6 × 1.2 | T2aNo | ++; c |
| DG | F/38 | PTC | 1 | T1aNo | ++; c |
| KJ | F/41 | PTC | 1.1 | T2aNo | +++; c |
| ZM | F/21 | PTC | 2.5 | T2aN1a | 0 |
| GJ | F/51 | PTC | 2 | T2aNo | +++; c |
| WB | F/22 | PTC | 5 × 6 × 6 | T3aN1b | 0 |
| CA | F/37 | PTC | 1.1 × 1.2 | T2aNo | +++; c |
| LA | F/32 | PTC | 1.4 | T2aNo | +++; c |
| FJ | F/47 | PTC | 1.8 | T2aNo | +++; c |
| BW | F/31 | PTC | 2.2 | T2aNo | +++; c |
| KP | F/27 | PTC | 1.3 | T2aNo | +++; c |
| WJ | F/53 | PTC | 1.2 | T2aNo | +++; c |
| PM | F/38 | PTC | 1.7 | T2aNo | +++; c |
| PT | F/44 | FTC | 6 | T3 | ++; c |
| UB | M/65 | FTC | 4.8 × 3.6 | T3 | 0 |
| BJ | F/45 | FTC | 3 | T2 | +++; c |
| NE | F/65 | FTC | 3.5 | T2 | +++; c |
| FE | F/23 | FTC | 3 | T2 | ++; c |
| SL | M/44 | FTC | 3.5 | T2 | +++; c |
| MB | F/38 | FTC | 1.4 | T2 | +++; c |
| WM | F/67 | FTC | 2.8 × 2.5 | T2 | 0 |
| SA | F/30 | FTC | 1.6 | T2 | ++; c |
| WS | F/58 | FTC | 2.8 | T2 | +++; c |
| GM | F/53 | FTC | 1.3 | T2 | ++; c |
| DS | F/47 | FTC | 1.4 × 1.8 | T2 | ++; c |
| PJ | F/81 | FTC | 2.2 × 1.6 | T2 | +++; c+m |
| PA | F/18 | FTC | 6 | T2 | +++; c |
| ZZ | F/52 | FTC | 5.4 | T3 | 0 |
| DE | F/33 | F. adenoma | 3 | +++; c+m | |
| TR | F/57 | F. adenoma | 5 × 3 | ++; c+m | |
| SE | F/54 | F. adenoma | 2.8 × 2.2 | ++; c+m | |
| SB | F/48 | F. adenoma | 6 | ++; c+m | |
| DG | F/44 | F. adenoma | 2.5 × 3.5 | ++; c+m | |
| LM | F/49 | F. adenoma | 2 | ++; c | |
| UA | F/64 | F. adenoma | 2 | +++; c | |
| SJ | F/39 | F. adenoma | 1.2 | ++; c | |
| JM | F/43 | F. adenoma | 2.8 × 1.9 | +++; c | |
| SB | F/60 | F. adenoma | 2 | +++; c+m | |
| CA | F/46 | F. adenoma | 2.3 | ++; c | |
| BJ | F/37 | F. adenoma | 1.5 | +++; c+m | |
| JJ | F/76 | F. adenoma | 3.2 | +++; c | |
| WM | F/33 | F. adenoma | 5 | +++; m | |
| OB | F/31 | F. adenoma | 3 | +++; c |
Intensity score: 0=null; ++=moderate; +++=intense; c=cytoplasmic; m=membranous; F=focal.